Pharmicell Co., Ltd.
South Korea
- Verified Certificate
-
12
| Product name | By Pharmicell Lab Dual Hydrogel Mask_30g | Certification | - |
|---|---|---|---|
| Category | Face Mask | Ingredients | - |
| Keyword | - | Unit Size | - |
| Brand name | - | Unit Weigh | - |
| origin | Stock | - | |
| Supply type | - | HS code | - |
Product Information
Dual Hydrogel Mask, The start and completion to get transparent and resilient skin By Pharmicell Lab Dual Hydrogel Mask 30g
Product introduction
| By Phrmicell Lab Dual Hydrogel Mask By Pharmicell Lab Dual Hydrogel Mask_30g |
Containing 3% of liposome extract of human bone marrow stem cell conditioned media / Functional cosmetic for wrinkle alleviation and whitening
Liposome extract of human bone marrow stem cell conditioned media and components of adenosine niacinamide will take care of your wrinkles When attached on your face, the excellent hydrogel mask will wrap the skin compactly and the content will pervade into the skin, leaving soft and silky feeling without any stickiness.
Main Ingredients
- Contains 3% of Human bone marrow stem cell conditioned media, Extract of Portulaca Oleracea, Adenosine, Niacinamide, Sodium Hyaluronate.
How to use
- After washing your face, apply a toner to clean up your skin.
- Open the pouch and remove the film on both sides that are separated into top and bottom
- Make sure the side where the transparent film is removed should be adhered onto the skin. For the upper half of your face, focus on the mouth as the center and put them onto the skin softly
- Remove the mask after 20~40 minutes and tap the remaining contents onto the skin so that it absorbs.
B2B Trade
| Price (FOB) | Negotiable | transportation | - |
|---|---|---|---|
| MOQ | Negotiable | Leadtime | Negotiable |
| Payment Options | Negotiable | Shipping time | Negotiable |
- President
- Hyeonsoo Kim
- Address
- 12F, Chungho-B/D, 3-2, Nonhyeon-dong, Gangnam-gu, Seoul, Korea
- Product Category
- Makeup Brushes
- No. of Total Employees
- 101-500
- Company introduction
-
Pharmicell is devoting itself to the development and commercialization if stem cell therapeutics for the conquest of incurable diseases such as cancer, brain and nervous system disorders, heart diseases that are the most fatal to human beings. Pharmicell is planning to accelerate the development of stem cell therapeutics for acute ischemic stroke(IND-phase 3)and chronic spinal cord injury(IND-phase 2/3)with the experiences relating to the NDA approval of stem cell therapeutics for acute myocardial infarction. In addition, we will continuously launch stem cell therapeutics according to our new drug development pipeline to treat alcoholic cirrhosis, pulmonary fibrosis, and cancer under investigator?s trials and thereby give hope to the patients who are suffering from these incurable diseases. Moreover, we will contribute to the vitalization of the industry related to stem cells through commercialization of stem cell therapeutics, stem cell banking, cell media, CMO(contract Manufacturing Organization), stem cell culturing media, cell processing equipment, cell transport box, manufacturing and quality control software by utilizing our know-how accumulated in the process of commercialization of stem cell therapeutics. This company has secured the intellectual property rights through the registration of patent for stem cell differentiation technology(dendritic cell production technology for anticancer immune treatment and production technology of nerve cells for treatment of brain and nervous system disorders) in foreign countries(7 countries including the US and EU) in order to gain technological competitive edge in the global markets.
- Main Product
_2.jpg "KONAD ILOJE Face Spa Mask_Heating_Cooling _6sheet__1")
